Litcius/Paper detail

Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of <i>Neisseria gonorrhoeae</i>

Nader S. Abutaleb, Ahmed E. M. Elhassanny, Alessio Nocentini, Chad S. Hewitt, Ahmed Elkashif, Bruce R. Cooper, Claudiu T. Supuran, Mohamed N. Seleem, Daniel P. Flaherty

2021Journal of Enzyme Inhibition and Medicinal Chemistry58 citationsDOIOpen Access PDF

Abstract

agents.

Topics & Concepts

AcetazolamideNeisseria gonorrhoeaeChemistryCarbonic anhydrasePotencyPharmacologyMicrobiologyEnzymeInternal medicineIn vitroBiochemistryMedicineBiologyEnzyme function and inhibitionSynthesis and Catalytic ReactionsPhenothiazines and Benzothiazines Synthesis and Activities
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of <i>Neisseria gonorrhoeae</i> | Litcius